RESUMO
The Centers for Disease Control and Prevention has classified Bacillus anthracis, the causative organism of anthrax, as a category A potential bioterrorism agent. There are critical shortcomings in the US anthrax vaccine program. Rather than depending on the private sector, the government must assume direct production of anthrax vaccine. The development of a capacity capable of preemptive immunization of the public against anthrax should be considered.
Assuntos
Vacinas contra Antraz , Antraz/prevenção & controle , Biotecnologia , Bioterrorismo , Desenho de Fármacos , Governo Federal , Política de Saúde , Saúde Pública , Animais , Vacinas contra Antraz/administração & dosagem , Antibacterianos/uso terapêutico , Cricetinae , Humanos , Vacinação em Massa , Mesocricetus , National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division , Política , Setor Privado , Política Pública , Estados Unidos , United States Dept. of Health and Human ServicesRESUMO
In the event of an influenza pandemic, where effective vaccine and antiviral drugs may be lacking, disrupting environmental transmission of the influenza virus will be the only viable strategy to protect the public. We discuss 2 such modalities, respirators (face masks) and ultraviolet (UV) light. Largely overlooked, the potential utility of each is underappreciated. The effectiveness of disposable face masks may be increased by sealing the edges of the mask to the face. Reusable masks should be stockpiled, because the supply of disposable masks will likely prove inadequate. UV light, directed overhead, may be beneficial in hospitals and nursing homes.
